His research, which focuses on drug delivery and bioelectronic therapeutics, has been featured in news outlets such as The New York Times, NPR, and Wired. Dr. Abramson has received several recognitions for scientific innovation, including being named a member of the Forbes 30 Under 30 Science List and the MIT Technology Review Innovators Under 35 List. Dr. Abramson is passionate about translating scientific endeavors from bench to bedside. Large pharmaceutical companies have exclusively licensed a portfolio of his patents to bring into clinical trials, and Dr. Abramson serves as a scientific advisor overseeing their commercialization. In addition to his scientific endeavors, Dr. Abramson plays an active role in his community by leading Diversity, Equity, and Inclusion efforts on campus and volunteering as a STEM tutor to local students.